Company intelligence / Profile preview

Byotrol

Chester, England, United Kingdombyotrol.com ↗

Ownership: Private
Development stage: Other

Overview

Byotrol develops and commercializes a suite of proprietary antimicrobial technologies used in infection prevention products for healthcare, animal health, facilities management, and consumer markets. Their portfolio includes surface disinfectants with broad-spectrum efficacy against bacteria and viruses—including long-lasting germ-kill claims—and skin disinfectants such as the INVIRTU alcohol-free hand sanitizer. The company’s technologies are supported by robust scientific validation and regulatory approvals in major global markets

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeDeviceProtein
Industry: Consumable Medical Devices

Partnerships

SC Johnson Professional (alcohol free hand sanitisers)Tristel plc (surface care chemistries)Target Corporation for US retail launch of consumer products

Beyond the preview

Go deeper on Byotrol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Byotrol.

Explore the full profile